What 1nHealth does

1nHealth is a privately held clinical trial patient recruitment company founded in 2019 by Dan Brenner and headquartered in Orlando, Florida, operating as a fully remote organization with 50+ employees. The company provides end-to-end patient enrollment services to pharmaceutical sponsors, biotechnology firms, and contract research organizations (CROs), managing the entire recruitment funnel from digital outreach through site collaboration and last-patient-in. Its core technology is 1nData, a proprietary ISO 27001-certified and HIPAA-compliant study data hub that delivers real-time patient tracking, automated SMS communications, site-by-site performance comparisons, and disqualification analytics.

The company's service portfolio spans Patient Enrollment Solutions, Study Feasibility & Validation, and Clinical Study Analysis, supplemented by The Site Exchange community platform for clinical research site personnel. 1nHealth has integrated an AI-powered voice agent, built on Retell AI, that automates structured eligibility screening calls with prospective patients. The company sells through a direct enterprise field-sales motion, targeting large pharma, mid-cap biotech, and CRO buyers globally across North America and Europe.

1nHealth operates on a milestone-based, outcome-aligned pricing model tied to enrollment events such as signed ICFs or patient randomization, creating a shared-risk revenue structure with sponsors. The company reports 150+ studies successfully recruited, 30K+ patients enrolled, and 800+ research sites using its platform across 20+ therapeutic areas. Named customers include Bayer, AbbVie, Sumitomo Pharma, Biohaven, Click Therapeutics, Curevo, Cook Research, Reunion Neuroscience, and MGTx. Strategic partnerships with IQVIA, ObvioHealth, THREAD, and Curavit integrate 1nHealth into the decentralized clinical trial technology ecosystem.

Name

1nHealth

Legal name

1nHealth Inc.

Website

https://1nhealth.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

1nHealth is a privately held clinical trial patient recruitment company that provides end-to-end digital enrollment services to pharmaceutical sponsors, biotech firms, and CROs, powered by its proprietary 1nData platform and milestone-based pricing tied to enrollment outcomes.

Ownership category

akta.pro rank

Product category

Clinical Trial Patient Recruitment Services

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)

SIC

Services-Health Services (8000)

akta.pro primary industry

Omnichannel Patient Communications & Contact Center (Voice/SMS/Email/Chat) (HLACAEAC)

akta.pro secondary industries

Patient Portals & Self-Service Access (HLACAEAA), Nurse Triage & Clinical Call-Center Teletriage Platforms (HLALAJAC)

Keywords

• Patient recruitment services
• Clinical trial enrollment
• Digital patient recruitment
• Clinical study feasibility
• Biotech enrollment solutions

Headquarters

HQ city

Orlando

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

1. Milestone-Based Enrollment Services: Pricing is based on specific milestones such as signed ICFs (Informed Consent Forms) or patient randomization. This aligns the company's revenue with sponsor success, creating a shared-risk model where payment is tied to enrollment outcomes rather than activities.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

1nHealth provides end-to-end digital patient recruitment and enrollment management services for clinical trials, owning the entire enrollment funnel from feasibility assessment and direct-to-patient outreach through pre-screening, site collaboration, and patient retention. Its proprietary 1nData platform supplies real-time patient tracking, automated communications, and site analytics for pharmaceutical sponsors, biotech firms, and CROs across multiple therapeutic areas.

Product overview

1nHealth offers a unified portfolio of clinical trial patient recruitment and enrollment services anchored by 1nData, its proprietary all-in-one study hub platform. The core offering consists of Patient Enrollment Solutions (direct-to-patient recruitment, multi-level screening, site support), Study Feasibility & Validation (pre-launch enrollment modeling and protocol optimization), and Clinical Study Analysis (real-world evidence and market intelligence). The ecosystem is supplemented by The Site Exchange, a free community platform for site personnel. 1nData serves as the technology backbone, powering real-time patient tracking, automated communications, and site analytics across all service lines.

Differentiator

Problem solved

Functional benefit

Brands

• 1nData: The company's proprietary all-in-one centralized study data hub and patient tracking platform that provides real-time site comparison dashboards, automated patient communication tools, and patient activity tracking capabilities.

Products and services

• 1nData Platform All-in-one centralized study data hub providing real-time patient data visibility, automated SMS and email notifications, patient activity tracking, site-by-site performance comparisons, disqualification metrics, and an AI-powered voice agent for eligibility screening. Designed for pharmaceutical sponsors, biotech firms, CROs, and research sites running clinical trials.
• Patient Enrollment Solutions End-to-end patient recruitment services encompassing targeted outreach, multi-level pre-screening, site collaboration, study branding, print materials, HCP engagement, and patient registry management to accelerate enrollment timelines for pharmaceutical sponsors, biotech firms, and CROs.
• Study Feasibility & Validation Data-driven feasibility assessments and protocol optimization services including enrollment model validation, study design guidance, regulatory compliance advisement, site selection analytics via 1nData, and patient journey mapping to identify enrollment barriers before launch.
• Clinical Study Analysis Real-world evidence generation and market intelligence services including RWE assessments for regulatory submissions, therapy opportunity identification, and strategic commercialization support to guide investment and expansion decisions.

Quantifiable outcome

• 4x faster enrollment compared to previous recruitment vendor
• +5 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

Five partnerships are on record, tiered core and minor.

• IQVIAcoreTechnology or IntegrationListed partner in IQVIA's 'One Home for Sites' Partner Program, enabling integration with IQVIA's site network and technology ecosystem for clinical trial operations.
• ObvioHealthcoreStrategic or Co-development PartnerCollaboration supporting decentralized and hybrid clinical trials, combining 1nHealth's recruitment expertise with ObvioHealth's decentralized trial platform capabilities.
• THREADcoreTechnology or IntegrationPartnership to optimize participant recruitment integration in decentralized studies, connecting recruitment workflows with THREAD's DCT technology platform.
• Curavit Clinical ResearchminorStrategic or Co-development PartnerDigital recruitment collaboration for decentralized trial programs, combining digital patient recruitment with Curavit's virtual trial capabilities.
• The MightyminorGTM or Marketing PartnerPatient community redirection initiative for individuals who do not qualify for specific clinical trials, connecting them with The Mighty's patient community for ongoing support and information.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Antidote (now part of Medable): Antidote was a direct competitor in digital patient recruitment for clinical trials, acquired by Medable. Both companies used digital outreach, multi-level screening, and patient engagement technology to accelerate trial enrollment for pharma sponsors.
• SubjectWell: SubjectWell provides patient recruitment services for clinical trials through a direct-to-patient marketplace model. Both companies target pharmaceutical sponsors and CROs and compete on enrollment speed, patient qualification, and tech-enabled outreach.
• Deep 6 AI: Deep 6 AI uses AI and NLP to match patients to clinical trials, focusing on accelerating trial enrollment through real-world data mining. Comparable in mission (accelerating enrollment) but differentiated by their site-side EHR data approach vs. 1nHealth's direct-to-patient model.

Broad incumbents

• IQVIA: IQVIA is the largest CRO with comprehensive patient recruitment capabilities as part of its broader clinical research services portfolio. Listed as a 1nHealth partner in the One Home for Sites program. Represents both a channel partner and a broad incumbent competing for sponsor recruitment budgets.
• Parexel International: Parexel is a major global CRO offering patient recruitment as part of its full-service clinical operations. Competes for the same pharma and biotech sponsor budgets but as one capability within a much broader service portfolio.
• Medidata (Dassault Systèmes): Medidata provides the Rave clinical trial technology platform used by many sponsors. While not a direct recruitment competitor, it overlaps in trial operations and offers patient-centric capabilities that intersect with 1nHealth's 1nData platform.

Emerging players

• THREAD: THREAD provides decentralized clinical trial technology platform. Listed as a 1nHealth partner for DCT recruitment integration, but also offers complementary capabilities that could compete in adjacent enrollment workflows.
• ObvioHealth: ObvioHealth is a decentralized clinical trial provider with their own patient recruitment capabilities. Listed as a 1nHealth collaboration partner for DCT programs; the partnership suggests partial overlap in recruitment with ObvioHealth's broader DCT focus.
• Curebase: Curebase is a decentralized clinical trial software provider with built-in patient recruitment features. Comparable in targeting decentralized trial execution and patient engagement but with a more software-centric model vs. 1nHealth's services-plus-tech approach.
• Clarify Health: Clarify Health provides real-world data and analytics for healthcare including clinical trial feasibility and patient identification. Adjacent to 1nHealth's Clinical Study Analysis service line and offers overlapping capabilities in patient journey mapping and trial feasibility.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/1nhealth
• Xx.com/1nHealth

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 1nHealth